CIK 0001829802 · <br>Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Grant or award 10% owner acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4/A Open-market buy Director bought 1,203 shares at $3.20 ($3,850)
- 4/A Open-market buy 10% owner bought 1,203 shares at $3.20 ($3,850)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Director bought 9,500 shares at $14.34 ($136,230)
- 4/A Open-market buy Director bought 752 shares at $19.75 ($14,852)
- 4/A Open-market buy 10% owner bought 9,500 shares at $14.34 ($136,230)
- 4/A Open-market buy 10% owner bought 752 shares at $19.75 ($14,852)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
Page 6 of 13 · 245 filings